Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Bruno Garibaldi
Observed name:
B. Garibaldi
Institution:
Azienda Ospedaliero Universitaria Policlinico "G.Rodolico - San Marco"
Observed institutions:
University of Catania,
Policlinico Universitario di Catania,
Azienda Ospedaliero Universitaria Policlinico "G.Rodolico - San Marco",
IRCCS Humanitas Research Hospital
ORCID:
0000-0001-7540-805X
Observed ORCID:
0000-0001-7540-805X
OpenAlex ID:
A5014501048
Prevention and Treatment of Acute Myeloid Leukemia Relapse after Hematopoietic Stem Cell Transplantation: The State of the Art and Future Perspectives
2022
·
Salvatore Leotta
, Annalisa Condorelli
, et al.
·
Journal of Clinical Medicine
·
67
PDF
Endothelial Dysfunction after Hematopoietic Stem Cell Transplantation: A Review Based on Physiopathology
2022
·
Giuseppe Milone
, Claudia Bellofiore
, et al.
·
Journal of Clinical Medicine
·
57
PDF
Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network
2019
·
Concetta Conticello
, Alessandra Romano
, et al.
·
Journal of Clinical Medicine
·
29
PDF
Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database
2021
·
Lucia Gozzo
, Calogero Vetro
, et al.
·
Frontiers in Pharmacology
·
25
PDF
Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting
2022
·
Andrea Duminuco
, Antonella Nardo
, et al.
·
Journal of Clinical Medicine
·
22
PDF
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials
2022
·
Enrica Antonia Martino
, Concetta Conticello
, et al.
·
Hematological Oncology
·
17
Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera: the “RAMP” Italian multicenter prospective study
2024
·
F. Palandri
, G. Auteri
, et al.
·
Annals of Hematology
·
16
PDF
Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study
2023
·
Francesca Palandri
, Elena Rossi
, et al.
·
Cancers
·
16
PDF
Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real‐life setting: An Italian MYNERVA Project
2023
·
Giacomo Coltro
, Emanuela Sant'Antonio
, et al.
·
Cancer Medicine
·
16
PDF
Multiple Myeloma in 2023 Ways: From Trials to Real Life
2023
·
Manlio Fazio
, Vittorio Del Fabro
, et al.
·
Current Oncology
·
15
PDF
Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients
2021
·
Fortunato Morabito
, Elena Zamagni
, et al.
·
European Journal Of Haematology
·
12
PDF
Handheld Ultrasound or Conventional Ultrasound Devices in Patients Undergoing HCT: A Validation Study
2023
·
Andrea Duminuco
, Alessandra Cupri
, et al.
·
Journal of Clinical Medicine
·
9
PDF
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials
2022
·
Fortunato Morabito
, Elena Zamagni
, et al.
·
Frontiers in Oncology
·
8
BTK Inhibition in Hematology: From CLL/SLL to Emerging Applications Across B-Cell and Immune Disorders
2026
·
Andrea Duminuco
, Paola De Luca
, et al.
·
Biomolecules
·
7
PDF
Old Therapy, New Questions: Rethinking Phlebotomy in a Pharmacologic Landscape
2025
·
Andrea Duminuco
, Patrick Harrington
, et al.
·
Pharmaceuticals
·
5
PDF
Impact of daratumumab on collection and engraftment in multiple myeloma patients undergoing hematopoietic stem cell mobilization with G-CSF plus on-demand plerixafor
2024
·
Giuseppe Bertuglia
, Bruno Garibaldi
, et al.
·
Bone Marrow Transplantation
·
5
PDF
Role of Serum Free Light Chain Assay in Relapsed/Refractory Multiple Myeloma. A Real-Life Unicentric Retrospective Study
2021
·
Uros Markovic
, Alessandra Romano
, et al.
·
Cancers
·
5
PDF
Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia
2025
·
Calogero Vetro
, Bruno Garibaldi
, et al.
·
Blood Cancer Journal
·
4
PDF
Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life study
2024
·
Salvatore Leotta
, Uros Markovic
, et al.
·
Annals of Hematology
·
4
PDF
Impact of Daratumumab on Hematopoietic Stem Cell Mobilization with G-CSF and on-Demand Plerixafor in Newly-Diagnosed Multiple Myeloma Patients
2023
·
Roberto Mina
, Bruno Garibaldi
, et al.
·
Blood
·
4
Previous therapy with immune checkpoint inhibitor as a cause of hypothyroidism, myositis, and renal insufficiency in a candidate for allogeneic hematopoietic transplantation
2022
·
Andrea Duminuco
, Alessandra Cupri
, et al.
·
Transplant Immunology
·
3
Regression of leukemia cutis with gilteritinib in a case of FLT3-positive acute myeloid leukemia
2022
·
Andrea Duminuco
, Francesco Di Raimondo
, et al.
·
Current Problems in Cancer Case Reports
·
3
PDF
P535: Updates From Italian Multicenter Real-life Experience on Cpx-351 Therapy in Young Patients (<60 Years Old).
2022
·
B. Garibaldi
, M. Franciosa
, et al.
·
HemaSphere
·
3
Response Assessment to Erythropoietin-Zeta (Epo-Alpha Biosimilar) Therapy in Low-Risk Myelodysplastic Syndromes
2022
·
Calogero Vetro
, Valeria Di Giacomo
, et al.
·
Journal of Clinical Medicine
·
3
PDF
Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the MPL Gene: Two Case Reports
2023
·
Maria Stella Pennisi
, Sandra Di Gregorio
, et al.
·
Hematology Reports
·
2
PDF
Show more works
View as search
Works count:
37
Citation count:
369
H-index:
11
I10-index:
11
Year
Topic
Type